London Pharma Funding Rounds 2026

Every London-based UK Pharma funding round filed in 2026, sourced direct from Companies House filings. Updated weekly.

London Pharma Funding Rounds 2026

CompanyRaisedRoundDate
Myricx Pharma£640k-2026/09/02
Kodiform Therapeutics£5.0MSeed2026/08/11
Tollcyto Therapeutics£415k-2026/07/28
Ventrazym£82k-2026/07/05
Implexis£250kSeed2026/07/01
Verdiva Bio£90.3M-2026/05/26
Exogene£138k-2026/05/21
Duke Street Bio£10.8M-2026/05/20
Rentschler Atmp£48k-2026/04/22
Ion Therapeutics£2.0MSeed2026/04/22
Engitix£9.4M-2026/04/16
Bioorbit£10.5MSeed2026/04/15
Resolution Therapeutics£25.0M-2026/04/09
Dyna Therapeutics£3.7M-2026/04/07
Endlyz Uk£1.9M-2026/03/30
Atocap£239kPre Seed2026/03/11
Myricx Pharma£39.6MSeries C Plus2026/03/03
Celadon Pharmaceuticals£30kSeries C Plus2026/02/17
Verdiva Bio£50.0M-2026/02/02
Early Health£957kSeed2026/01/23
Faber Research And Technologies£1.5M-2026/01/09

More London funding rounds